Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:43 pm Purchase | 2025-09-30 | 13G | EVOLUS INC EOLS | Nantahala Capital Management, LLC | 5,726,857 8.850% | 1,975,514![]() (+52.66%) | Filing History |
| 2025-11-14 4:41 pm Purchase | 2025-09-30 | 13G | EVENTBRITE INC EB | Nantahala Capital Management, LLC | 6,831,395 8.450% | 900,448![]() (+15.18%) | Filing History |
| 2025-11-14 4:40 pm Purchase | 2025-09-30 | 13G | EHEALTH, INC. EHTH | Nantahala Capital Management, LLC | 1,761,441 5.760% | 450,000![]() (+34.31%) | Filing History |
| 2025-11-14 4:40 pm Sale | 2025-09-30 | 13G | ENVVENO MED CORP COM NVNO | Nantahala Capital Management, LLC | 19,684 3.460% | -17,055![]() (-46.42%) | Filing History |
| 2025-11-14 4:40 pm Purchase | 2025-09-30 | 13G | DARIOHEALTH CORP COM PAR 0.000 DRIO | Nantahala Capital Management, LLC | 568,844 9.990% | 334,343![]() (+142.58%) | Filing History |
| 2025-11-14 4:39 pm Purchase | 2025-09-30 | 13G | X4 PHARMACEUTICALS INC XFOR | Nantahala Capital Management, LLC | 2,244,319 9.990% | 2,244,319![]() (New Position) | Filing History |
| 2025-11-14 4:39 pm Sale | 2025-09-30 | 13G | VERASTEM INC VSTM | Nantahala Capital Management, LLC | 4,626,236 7.130% | -833,042![]() (-15.26%) | Filing History |
| 2025-11-14 4:38 pm Purchase | 2025-09-30 | 13G | DESTINATION XL GROUP INC DXLG | Nantahala Capital Management, LLC | 4,505,000 8.360% | 4,505,000![]() (New Position) | Filing History |
| 2025-11-14 4:37 pm Sale | 2025-09-30 | 13G | COMPASS PATHWAYS PLC SPONSORED CMPS | Nantahala Capital Management, LLC | 3,484,315 3.570% | -2,450,000![]() (-41.29%) | Filing History |
| 2025-11-14 4:37 pm Purchase | 2025-09-30 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Nantahala Capital Management, LLC | 3,185,564 9.990% | 351,228![]() (+12.39%) | Filing History |
| 2025-11-14 4:36 pm Purchase | 2025-09-30 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Nantahala Capital Management, LLC | 1,855,991 9.990% | 621,395![]() (+50.33%) | Filing History |
| 2025-11-14 4:36 pm Purchase | 2025-09-30 | 13G | ANTERIS TECHNOLOGIES GLOBAL CO AVR | Nantahala Capital Management, LLC | 1,918,666 5.320% | 1,918,666![]() (New Position) | Filing History |
| 2025-11-14 4:36 pm Sale | 2025-09-30 | 13G | THERATECHNOLOGIES INC THTX | Nantahala Capital Management, LLC | 0 0.000% | -2,682,228![]() (Position Closed) | Filing History |
| 2025-11-14 4:35 pm Purchase | 2025-09-30 | 13G | TRISALUS LIFE SCIENCES INC TLSI | Nantahala Capital Management, LLC | 2,040,245 4.090% | 40,245![]() (+2.01%) | Filing History |
| 2025-11-14 4:35 pm Purchase | 2025-09-30 | 13G | ALTISOURCE PORTFOLIO SOLUTIONS ASPS | Nantahala Capital Management, LLC | 1,006,408 8.390% | 696,744![]() (+225.00%) | Filing History |
| 2025-11-14 4:35 pm Sale | 2025-09-30 | 13G | THIRD HARMONIC BIO INC THRD | Nantahala Capital Management, LLC | 0 0.000% | -2,938,700![]() (Position Closed) | Filing History |
| 2025-11-14 4:34 pm Purchase | 2025-09-30 | 13G | 1-800 FLOWERS.COM INC FLWS | Nantahala Capital Management, LLC | 3,368,065 9.210% | 1,368,065![]() (+68.40%) | Filing History |
| 2025-11-14 4:33 pm Purchase | 2025-09-30 | 13G | SAVARA INC SVRA | Nantahala Capital Management, LLC | 8,775,375 5.080% | 8,775,375![]() (New Position) | Filing History |
| 2025-11-14 4:32 pm Sale | 2025-09-30 | 13G | RAPT THERAPEUTICS INC RAPT | Nantahala Capital Management, LLC | 623,282 3.770% | -328,331![]() (-34.50%) | Filing History |
| 2025-11-14 4:32 pm Purchase | 2025-09-30 | 13G | QUINCE THERAPEUTICS, INC QNCX | Nantahala Capital Management, LLC | 562,042 9.990% | 85,456![]() (+17.93%) | Filing History |

